Primary hyperparathyroidism associatiated with aldosterone-producing adrenocortical adenoma and breast cancer: Relation to MEN1 gene

Internal Medicine

Volumn 43, Issue 4, 2004, Pages 310-314

  Honda, Munehiro ^c   Tsukada, Toshihiko ^a   Horiuchi, Toshimitsu ^c   Tanaka, Reiko ^b   Yamaguchi, Ken ^a   Obara, Takao ^b   Miyakawa, Hiroshi ^c   Yamaji, Tohru ^d   Ishibashi, Miyuki ^c  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NONE

Author keywords

Breast cancer; Loss of heterozygosity; MEN1 gene; Multiple endocrine neoplasia type 1 (MEN1); Primary aldosteronism; Primary hyperparathyroidism

Indexed keywords

ALDOSTERONE; CALCIUM; NIFEDIPINE; PARATHYROID HORMONE; POTASSIUM; SPIRONOLACTONE; TUMOR SUPPRESSOR PROTEIN;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ALDOSTERONE RELEASE; ARTICLE; BLOOD PRESSURE REGULATION; BREAST CANCER; CASE REPORT; CHROMOSOME 11Q; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPERTENSION; HYPOKALEMIA; MASTECTOMY; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROID ADENOMA; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; PRIMARY HYPERPARATHYROIDISM; ZONA GLOMERULOSA;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADULT; ALDOSTERONE; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HUMANS; HYPERALDOSTERONISM; HYPERPARATHYROIDISM; LOSS OF HETEROZYGOSITY; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PARATHYROID NEOPLASMS; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 2542461311     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.310     Document Type: Article

References (15)

1. Brandi ML, Marx SJ, Aurbach GD, Fitzpatrick LA. Familial multiple endocrine neoplasia type 1: a new look at pathophysiology. Endocr Rev 8: 391-405, 1987.
2. Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332: 85-87, 1988.
3. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276: 404-407,1997.
4. The European Consortium on MEN1. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet 6: 1177-1183, 1997.
5. Thakker RV, Bouloux P, Wooding C, et al. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 321: 218-224, 1989.
6. Farnebo F, Teh BT, Kytölä S, et al. Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab 83: 2627-2630, 1998.
7. Carling T, Correa P, Hessman O, et al. Parathyroid MEN1 gene mutations in relation to clinical characteristics of non-familial primary hyperparathyroidism. J Clin Endocrinol Metab 83: 2960-2963, 1998.
8. Honda M, Tsukada T, Tanaka H, et al. A novel mutation of the MEN1 gene in a Japanese kindred with familial isolated primary hyperparathyroidism. Eur J Endocrinol 142: 138-143, 2000.
9. Miyauchi A, Sato M, Matsubara S, et al. A family of MEN1 with a novel germline missense mutation and benign polymorphisms. Endocrine 145: 753-759, 1998.
10. Herman JG, Latif F, Weng Y, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700-9704, 1994.
11. Beckers A, Abs R, Willems PJ, et al. Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): Loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus. J Clin Endocrinol Metab 75: 564-570, 1992.
12. Iida A, Blake K, Tunny T, et al. Allelic losses on chromosome band 11q13 in aldosterone-producing adrenal tumors. Genes Chromosom Cancer 12: 73-75, 1995.
13. Moore EW. Ionized calcium in normal serum, ultrafiltrates, and whole blood determined by ion-exchange electrodes. J Clin Invest 49: 318-334, 1970.
14. Resnick LM, Laragh JH. Calcium metabolism and parathyroid function in primary aldosteronism. Am J Med 78: 385-390, 1985.
15. Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C. Alternations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Am J Hypertens 8: 884-893, 1995.